SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Northern Oil & Gas entered into a material asset purchase agreement on May 22, 2026, to acquire oil and gas properties from Parallax Energy Operating Inc. for CA$237.0 million in cash plus CA$113.0 million in stock consideration, with potential contingent consideration of CA$25.0 million.
View raw filing on EDGAR →Champion Homes disclosed results of operations and financial condition for the quarter ended March 28, 2026, with a press release furnished as Exhibit 99.1.
View raw filing on EDGAR →The Board approved a $50 million increase to the share repurchase program, bringing the total authorization to $150 million, reflecting management's confidence in the company's financial position.
View raw filing on EDGAR →Olema announced entry into a clinical trial collaboration and supply agreement with Bayer to evaluate OP-3136 (Olema's KAT6 inhibitor) in combination with NUBEQA® (darolutamide) in a Phase 1b/2 study for metastatic castration-resistant prostate cancer. This strategic partnership represents a material development for Olema's pipeline and commercial prospects.
View raw filing on EDGAR →Silicon Labs discloses that the HSR Act waiting period for its merger with Texas Instruments expired on May 22, 2026, satisfying a key condition to closing. The filing updates investors on material progress toward completion of the previously announced merger transaction, which constitutes a material acquisition/change of control event under Item 8.01 (Other Events).
View raw filing on EDGAR →Strategy Inc disclosed capital structure updates via press release and maintained a dashboard of capital structure information under Regulation FD Disclosure, though the specific nature of the updates is not detailed in the filing excerpt provided.
View raw filing on EDGAR →Strategy Inc updated investors on its material holdings and liquidity position, disclosing approximately 843,738 bitcoin valued at ~$63.87 billion and a USD Reserve of $871 million designated for dividend and debt service obligations.
View raw filing on EDGAR →The filing discloses the separation of Ambaw Bellete, President & Chief Operating Officer, effective June 30, 2026. While the section also mentions Arthur Kuan's appointment as President, the primary focus and substantive disclosure centers on Bellete's departure and associated severance benefits under his employment agreement. The departure of a C-suite officer (President & COO) is material to investors.
View raw filing on EDGAR →Graphic Packaging entered into a $141.4 million loan agreement with MEDC to finance tax-exempt green bonds due 2064, creating a direct financial obligation under Item 2.03. While this is a material financing event affecting the company's capital structure and debt profile, it does not fit cleanly into the more specific event categories (e.g., it is not a covenant breach, dilutive issuance, or M&A activity). The green bond financing is material to investors as it represents a significant long-term debt obligation, but the disclosure is primarily a financing arrangement rather than a triggering event like a breach or impairment.
View raw filing on EDGAR →ASP Isotopes disclosed a press release and investor presentation regarding the Company's production of Silicon-28, a specialized isotope product. While the disclosure is made under Item 7.01 (Regulation FD Disclosure) and explicitly disclaimed as not "filed" under Section 18, the announcement of a significant production achievement for a specialized isotope company could be material to investors assessing the company's operational progress and commercial viability. However, the filing does not provide specific details about production volumes, commercial significance, or financial impact, making it difficult to classify into a more specific event category; thus "other_material" is most appropriate.
View raw filing on EDGAR →The filing discloses a $900 million private offering of senior secured notes by a subsidiary, with proceeds intended to fund the Klöckner Acquisition and refinance existing debt. While the notes are debt rather than equity, the offering is material and raises capital for a major acquisition. However, this is primarily a debt financing announcement in connection with M&A activity, which may be better classified as ma_activity given the central role of the Klöckner Acquisition in the disclosure.
View raw filing on EDGAR →PBF Energy announced a $500 million private offering of senior unsecured notes due 2034, with proceeds intended to redeem $801.6 million of 2028 Notes, representing a material refinancing of the company's debt structure.
View raw filing on EDGAR →Corbus Pharmaceuticals disclosed updated Phase 1/2 clinical data for CRB-701 (SYS6002), a Nectin-4 targeted ADC, demonstrating robust activity in oropharyngeal squamous cell carcinoma (OPSCC) and cervical cancer, with results to be presented at ASCO 2026 and FDA alignment on registrational trial designs.
View raw filing on EDGAR →National Fuel Gas Company disclosed a material acquisition of Vectren Energy Delivery of Ohio, LLC from CenterPoint Energy Resources Corp. for $2.62 billion under a Securities Purchase Agreement entered into on October 20, 2025. The filing provides consolidated financial statements and pro forma information for the target company, and the transaction is expected to close in Q4 2026 subject to regulatory approval from the Public Utilities Commission of Ohio. This is a material M&A activity requiring 8-K disclosure under Item 1.01.
View raw filing on EDGAR →This disclosure reports the creation of direct financial obligations through the issuance of consolidated obligations (bonds and discount notes) by the Federal Home Loan Bank of Pittsburgh. While Item 2.03 is the appropriate disclosure vehicle for debt issuances, the filing does not fit cleanly into the "covenant_breach" category (which signals financial distress) or other specific event types. The FHLBank explicitly states that "consolidated obligations issuance is material to the FHLBank," and Schedule A details committed debt issuances. This is a material debt financing event that warrants disclosure but lacks a more precise taxonomy match.
View raw filing on EDGAR →Alaunos announced an integrated preclinical readout for ALN1003, its investigational obesity candidate, disclosing results from non-GLP mouse studies. While this is a material development for a clinical-stage biotech company (affecting investor assessment of pipeline progress), it does not fit neatly into the standard taxonomy—it is neither an earnings release (financial results), nor a clinical trial result (no dedicated 8-K Item), nor a material impairment or litigation event. The disclosure is material because preclinical efficacy data for a lead candidate directly informs investor valuation and risk assessment, warranting classification as other_material.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from Velocity Financial's Annual Meeting of Shareholders held on May 21, 2026. The filing presents final voting tallies for three proposals: (1) election of eight directors, (2) advisory approval of named executive officer compensation, and (3) ratification of RSM US LLP as independent auditor. This is the quintessential Item 5.07 disclosure required by SEC rules following shareholder meetings.
View raw filing on EDGAR →This Item 5.07 filing discloses the results of CBL & Associates Properties' annual shareholder meeting held on May 21, 2026, including: (1) election of seven directors with vote tallies for each nominee, (2) ratification of Deloitte & Touche, LLP as independent auditors, and (3) advisory approval of executive compensation. The disclosure of shareholder vote results is the core purpose of Item 5.07 and is material to investors assessing board composition and governance outcomes.
View raw filing on EDGAR →Apollo Infrastructure Co LLC completed unregistered sales of equity securities totaling approximately $34.6 million across multiple share classes (Series I and Series II A-II, F-I, E, and I shares) to third-party investors under Section 4(a)(2) and Regulations D and S.
View raw filing on EDGAR →The filing discloses delivery of a proxy statement for an annual stockholders meeting scheduled for August 7, 2026. While proxy statements are routine corporate governance documents, the disclosure itself under Item 7.01 (Regulation FD Disclosure) does not fit cleanly into the shareholder_vote_results category, which applies to actual voting outcomes post-meeting. This is a pre-meeting disclosure of the proxy materials, which is material to shareholders but lacks a more specific event type in the taxonomy.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from Emerald Holding's May 21, 2026 Annual Meeting of Stockholders under Item 5.07. The filing reports voting outcomes on four proposals: re-election of three Class III directors (Michael Alicea, David Levin, Emmanuelle Skala), ratification of PricewaterhouseCoopers LLP as auditor, advisory approval of named executive officer compensation, and frequency of future advisory votes on compensation. All proposals passed with substantial majorities. This is material as it reflects stockholder approval of board composition and governance matters.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from the Company's 2026 Annual Meeting of Stockholders held on May 21, 2026. The filing reports final voting tallies for four proposals: election of three Class III directors (Michael Grey, Camilla V. Simpson, and Javier Szwarcberg), ratification of BDO USA, P.C. as independent auditor, advisory approval of named executive officer compensation, and advisory vote on frequency of future compensation votes. The detailed vote counts and the Company's stated determination to hold annual advisory votes on executive compensation based on these results are material to investors' understanding of governance and shareholder preferences.
View raw filing on EDGAR →The filing explicitly discloses that Box, Inc. issued a press release announcing financial results for the fiscal quarter ended April 30, 2026, with the full text attached as Exhibit 99.1. This is a standard quarterly earnings release disclosure under Item 2.02, which is material to investors as it provides the company's periodic financial performance.
View raw filing on EDGAR →Ken Moss (Chief Technology Officer) and Mary Kay Bowman (Executive Vice President and General Manager of Payments and Financial Services) are departing effective June 30, 2026. John Rettig is transitioning to Chief Strategy and Transformation Officer. The departures of two senior officers represent material changes to the company's executive leadership and operational capability.
View raw filing on EDGAR →Viridian entered into a Commercial Manufacturing Services Agreement with WuXi Biologics on May 24, 2026, for long-term supply of veligrotug drug substance and product for commercial use. While this is a manufacturing/supply agreement rather than a traditional M&A transaction, it constitutes a material definitive agreement under Item 1.01 that secures critical commercial supply infrastructure for the Company's lead product contingent on regulatory approval. The five-year initial term with automatic renewal, volume-based pricing, and binding commitments make this a material commercial arrangement that would affect investor assessment of the Company's commercialization readiness and operational risk.
View raw filing on EDGAR →This Item 5.07 disclosure reports the results of the 2026 annual stockholder meeting held on May 20, 2026, including the election of two Class II directors (Rachel H. Lee and Lily Yang) and ratification of Deloitte & Touche LLP as independent auditor, with specific vote tallies for each proposal. The disclosure directly matches the shareholder_vote_results event type, which covers results of votes at annual or special meetings of security holders.
View raw filing on EDGAR →Assembly Biosciences completed a registered public offering of 3,358,602 shares of common stock at $26.50 per share, plus pre-funded warrants to purchase 415,000 additional shares, raising approximately $107.4 million in net proceeds. Underwriters exercised their 30-day option to purchase 566,040 additional shares in full, further diluting existing shareholders.
View raw filing on EDGAR →The disclosure announces a press release containing historical financial results for fiscal years 2023 and 2024, preliminary estimated unaudited financial information for fiscal year 2025, and financial commentary for fiscal year 2026. This is a classic earnings release disclosure under Item 2.02, with the press release attached as Exhibit 99.1. The announcement of comprehensive annual financial results is material to investors assessing the registrant's financial performance and condition.
View raw filing on EDGAR →Urban Outfitters entered into a fifth amendment to its asset-based revolving credit facility on May 19, 2026, extending the maturity date to May 2031 and terminating the Canadian sub-facility. The extension of the $350 million revolving credit facility and restructuring of borrowing obligations materially affects the company's liquidity and financial flexibility.
View raw filing on EDGAR →Scott Beiser was appointed as a Class I director of Palomar Holdings, Inc., effective immediately, to serve until the 2029 Annual Meeting. The appointment was disclosed in Item 5.02 and furnished via press release in Item 7.01.
View raw filing on EDGAR →Palomar Holdings held its 2026 annual meeting on May 21, 2026, with shareholders voting on three proposals: election of two Class I Directors (Daryl Bradley and Thomas Bradley), advisory approval of named executive officer compensation, and ratification of Ernst & Young LLP as independent auditor. Final vote tallies were disclosed in Item 5.07.
View raw filing on EDGAR →Jonathan McNeill, a Board member of General Motors, notified the Board on May 26, 2026 that he will not stand for reelection and will retire from the Board upon conclusion of the 2026 Annual Meeting. This is a clear departure of a director. While the filing notes the retirement is not due to disagreement and expresses gratitude for his service, the principal disclosed action is a director leaving the Board, making this an exec_departure event. Board composition changes are material to investors assessing corporate governance.
View raw filing on EDGAR →Verra Mobility terminated its contract with Avis Budget Group, a major customer representing over 10% of total revenue in Q1 2026 and FY 2025, and revised full-year 2026 guidance downward as a result of this significant loss of revenue.
View raw filing on EDGAR →Exzeo announced authorization of a $12 million share repurchase program with a Rule 10b5-1 trading plan effective immediately. While share buybacks are routine capital allocation decisions, the $12 million authorization and formal adoption of a Rule 10b5-1 plan represent a material corporate action that signals management's confidence in valuation and capital deployment strategy. This does not fit neatly into the more specific event categories (not M&A, not compensation, not a departure/appointment), making "other_material" the most appropriate classification.
View raw filing on EDGAR →The filing discloses quarterly financial results for the period ended March 31, 2026, via a press release furnished as Exhibit 99.1. This is a standard earnings release disclosure under Item 2.02, which is material to investors as it provides periodic financial performance information about the registrant.
View raw filing on EDGAR →BlackRock Monticello Debt REIT entered into a First Amendment to its revolving credit agreement with JPMorgan Chase Bank on May 21, 2026, extending the maturity date to May 20, 2027 and modifying the applicable margin. This refinancing activity materially affects the Company's liquidity and debt obligations.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from Burlington Stores' annual meeting held May 19, 2026, covering four proposals: election of seven directors, ratification of Deloitte & Touche LLP as auditor, advisory Say-On-Pay vote, and frequency of future Say-On-Pay votes. The filing presents detailed vote tallies for each proposal, which is the core content of Item 5.07 (Submission of Matters to a Vote of Security Holders).
View raw filing on EDGAR →Shimmick Corporation entered into an Underwriting Agreement on May 22, 2026, for a public offering of 3,730,000 shares at $3.50 per share, with the underwriter exercising its option to purchase an additional 559,500 shares, resulting in total issuance of 4,289,500 shares and net proceeds of approximately $14.0 million. This is a material equity issuance that dilutes existing shareholders and represents a significant capital raise disclosed under Item 1.01.
View raw filing on EDGAR →The filing discloses adoption of two executive compensation arrangements: the Executive Severance Plan (ESP) establishing severance multiples for named executive officers (Tier I CEO at 3.0x, Tier II NEOs at 1.0-2.0x base salary plus target bonus), and an amended and restated Value Creation Incentive Plan (VCIP) providing cash incentive bonuses based on performance goals. These are compensatory arrangements affecting executive officers and named executives, directly within the scope of Item 5.02(e).
View raw filing on EDGAR →Callaway Golf held its 2026 Annual Meeting of Shareholders on May 21, 2026, with shareholders voting on three proposals: election of nine directors (including Thomas G. Dundon and Mark D. Mandel), ratification of Deloitte & Touche LLP as independent auditor, and advisory approval of named executive officer compensation. All proposals received shareholder approval.
View raw filing on EDGAR →The disclosure concerns an unsolicited tender offer from Zodiac Partners II and the Board's recommendation regarding it. This constitutes a material acquisition or change-of-control activity that would significantly affect investor assessment of the company's future. Tender offers and Board recommendations on potential acquisitions are core M&A events under Item 1.01/2.01 scope, even when disclosed via Item 7.01 Regulation FD.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from Viking Therapeutics' 2026 Annual Meeting of Stockholders held on May 19, 2026. The filing reports results on three proposals: election of Class II directors (J. Matthew Singleton and S. Kathryn Rouan, Ph.D.), ratification of CBIZ CPAs P.C. as independent auditor, and advisory approval of named executive officer compensation. The detailed vote tallies and passage of all three proposals constitute material shareholder actions that affect corporate governance and oversight.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from Vera Therapeutics' 2026 Annual Meeting of Stockholders held on May 21, 2026, covering three proposals: election of Class II directors (Morrisey, Enright, Meyers), ratification of KPMG LLP as independent auditor, and advisory approval of executive compensation. The filing presents final voting tallies for each matter, which is the hallmark of Item 5.07 shareholder_vote_results disclosures.
View raw filing on EDGAR →Fortress Private Lending Fund sold 431,701 Class I common shares for $10.4 million in aggregate consideration to accredited investors pursuant to Section 4(a)(2) and Regulation D exemptions, diluting existing shareholders and raising capital.
View raw filing on EDGAR →The Company disclosed material portfolio and financial metrics as of April 30, 2026, including NAV per Class I share of $24.16, aggregate NAV of approximately $1.1 billion, portfolio fair value of $1.8 billion, $763.8 million in debt outstanding, 88 portfolio companies, and a weighted average yield of 9.8%, along with a monthly distribution declaration of $0.1812 per Class I share.
View raw filing on EDGAR →MasterBrand discloses that the Federal Trade Commission has closed its investigation of the proposed merger with American Woodmark and the Hart-Scott-Rodino waiting period has expired, clearing the way for closing "on or about May 28, 2026." This is a material milestone in the completion of a merger transaction that was entered into on August 5, 2025, and represents a significant corporate event affecting the registrant's future operations and structure.
View raw filing on EDGAR →This is a clear Item 5.07 disclosure of shareholder vote results from the May 21, 2026 annual meeting of Republic Airways Holdings Inc. The filing reports voting outcomes for three proposals: election of six directors, advisory approval of named executive officer compensation, and ratification of Deloitte & Touche LLP as independent auditor. All three proposals passed with substantial majorities, and the detailed vote tallies (For/Against/Abstain/Broker Non-Votes) are presented for each proposal as required by Item 5.07.
View raw filing on EDGAR →American Woodmark discloses that the Federal Trade Commission has closed its investigation and the Hart-Scott-Rodino waiting period has expired for the company's proposed merger with MasterBrand, with closing expected on or about May 28, 2026. This represents a material milestone in the completion of a merger transaction that was entered into on August 5, 2025, and directly impacts the registrant's control and structure.
View raw filing on EDGAR →Richard Wohl, Executive Vice President and General Counsel since October 2011, is retiring effective June 5, 2026. While the filing also discloses accelerated vesting of equity awards (~$364,346), the principal disclosed action is the departure of a named executive officer from a senior legal role. The accelerated vesting is a severance-related accommodation rather than the primary event.
View raw filing on EDGAR →The filing discloses that exclusivity provisions in a non-binding letter of intent with Terra Quantum have expired, allowing MLAC II to pursue discussions with other potential business combination targets. While this is a development in M&A discussions, it does not constitute entry into, completion of, or termination of a material acquisition or change of control—the letter of intent was non-binding and exclusivity has merely lapsed. The event is material to investors as it affects the likelihood and scope of a potential business combination, but does not fit cleanly into the ma_activity category, which typically covers binding agreements or completed transactions.
View raw filing on EDGAR →